Summary
TherVacB aims to develop a therapeutic vaccine to cure patients living with chronic hepatitis B (CHB). According to WHOs Global Hepatitis Report 2024 an estimated 254 million people are living with hepatitis B and there are about 1.1 million deaths each year from the sequelae...
More information & hyperlinks
| Web resources: | https://www.thervacb.eu |
Search
Associated projects
Organisations
- Not specified